Global Finance News
30 Jan 2026, 15:59
Colgate-Palmolive reported mixed results for 2025, with modest sales growth but GAAP earnings pressured by impairment charges. Full-year net sales and organic sales both increased 1.4%, while GAAP EPS fell 25% to $2.63 due to goodwill and intangible asset impairments in the skin health business. Excluding these items, Base Business EPS rose 3% to $3.69. Operating cash flow reached a record $4.2 billion, and the company returned $2.9 billion to shareholders through dividends and buybacks.
In the fourth quarter, net sales rose 5.8% and organic sales increased 2.2%. GAAP EPS declined to a loss of $0.05, again reflecting impairment charges, while Base Business EPS grew 4% to $0.95. Colgate maintained its global leadership positions, with toothpaste market share at 41.3% and manual toothbrush share at 32.4%. Management said it entered 2026 from a position of strength, despite a challenging operating environment.
In the fourth quarter, net sales rose 5.8% and organic sales increased 2.2%. GAAP EPS declined to a loss of $0.05, again reflecting impairment charges, while Base Business EPS grew 4% to $0.95. Colgate maintained its global leadership positions, with toothpaste market share at 41.3% and manual toothbrush share at 32.4%. Management said it entered 2026 from a position of strength, despite a challenging operating environment.
